Discover open access scientific publications

Palliative Radiotherapy Given Concurrently or Within 4 Weeks of Initiation of Immunotherapy Is Associated With Sustained Clinical Response to Immune Checkpoint Inhibitors in Patients With Stage IV Non-Small Cell Lung Cancer (NSCLC)